Trade Summary

7 months ago, Manning Paul B, serving as Dir, 10% owner at Verrica Pharmaceuticals Inc. (VRCA), purchased 4,126,142 shares at $4.24 per share, for a total transaction value of $17,505,157.00. Following this transaction, Manning Paul B now holds 7,932,218 shares of VRCA.

This purchase represents a 108.00% increase in Manning Paul B's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, November 25, 2025 and publicly disclosed via SEC Form 4 filing on Tuesday, November 25, 2025 at 2:00 PM ET, meaning the disclosure happened on the same day as the trade.

Verrica Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.